retrothiorphan has been researched along with 3-mercaptopropionic acid in 1 studies
Studies (retrothiorphan) | Trials (retrothiorphan) | Recent Studies (post-2010) (retrothiorphan) | Studies (3-mercaptopropionic acid) | Trials (3-mercaptopropionic acid) | Recent Studies (post-2010) (3-mercaptopropionic acid) |
---|---|---|---|---|---|
18 | 0 | 2 | 639 | 1 | 201 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arbin, V; Claperon, N; FourniƩ-Zaluski, MC; Peyroux, J; Roques, BP | 1 |
1 other study(ies) available for retrothiorphan and 3-mercaptopropionic acid
Article | Year |
---|---|
Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Femoral Artery; Hemodynamics; Kininogens; Lysine Carboxypeptidase; Male; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Thiorphan; Time Factors | 2000 |